Shares of Cytokinetics Inc. (CYTK) slipped over 18% on Thursday morning after the biopharmaceutical company announced an expanded funding collaboration with Royalty Pharma totaling up to $575 million and a $500 million stock offering.
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.